UNITED LAB(03933),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

03933 UNITED LAB

Trading 02-27 09:53:58

12.970

+0.340

+2.69%

High13.130	Low12.690	Vol2.02M
Open12.690	D1 Closing12.630	Amplitude3.48%
Mkt Cap25.59B	Tradable Cap25.59B	Total Shares1.97B
T/O26.29M	T/O Rate0.10%	Tradable Shares1.97B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"03933","market":"HK","secType":"STK","nameCN":"UNITED LAB","latestPrice":12.97,"timestamp":1772157235170,"preClose":12.63,"halted":0,"volume":2024000,"delay":0,"changeRate":0.026920031670625483,"floatShares":1973000000,"shares":1973000000,"eps":1.463938,"marketStatus":"Trading","change":0.34,"latestTime":"02-27 09:53:58","open":12.69,"high":13.13,"low":12.69,"amount":26294800,"amplitude":0.034838,"askPrice":12.97,"askSize":24000,"bidPrice":12.95,"bidSize":10000,"shortable":3,"etf":0,"ttmEps":1.702,"tradingStatus":2,"nextMarketStatus":{"tag":"Noon Closed","tradingStatus":4,"beginTime":1772164800000},"marketStatusCode":2,"adr":0,"listingDate":1181836800000,"exchange":"SEHK","adjPreClose":12.63,"dividendRate":0.037937,"openAndCloseTimeList":[[1772155800000,1772164800000],[1772168400000,1772179200000]],"volumeRatio":3.15482,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/03933","defaultTab":"news","newsList":[{"id":"2614292220","title":"A Look At United Laboratories International Holdings (SEHK:3933) Valuation After Positive UBT251 Phase II Obesity Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2614292220","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614292220?lang=en_us&edition=fundamental","pubTime":"2026-02-26 23:30","pubTimestamp":1772119857,"startTime":"0","endTime":"0","summary":"United Laboratories International Holdings (SEHK:3933) and Novo Nordisk have reported Phase 2 data for obesity drug UBT251 in China, with plans to move into Phase 3 locally and to expand global studies.\nSee our latest analysis for United Laboratories International Holdings.\nThe Phase 2 obesity data arrives at a time when the share price has a HK$12.63 latest close and a 3 year total shareholder return above 200%. However, the 1 year total shareholder return of about a 5% decline suggests...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3933/united-laboratories-international-holdings-shares/news/a-look-at-united-laboratories-international-holdings-sehk393","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3933/united-laboratories-international-holdings-shares/news/a-look-at-united-laboratories-international-holdings-sehk393","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DCF","BK1191","03933","BK4211","UBCP"],"gpt_icon":0},{"id":"1158282428","title":"Weight-Loss Drug Developer United Lab Shares Surge as Global Giants Enter Chinese Market","url":"https://stock-news.laohu8.com/highlight/detail?id=1158282428","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158282428?lang=en_us&edition=fundamental","pubTime":"2026-02-25 14:51","pubTimestamp":1772002309,"startTime":"0","endTime":"0","summary":"As competition in the weight-loss drug market intensifies, multinational pharmaceutical giants are increasingly focusing on Chinese assets in this sector. On February 25, after the opening of...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","03933"],"gpt_icon":0},{"id":"2614347778","title":"United Laboratories Reports Positive China Phase 2 Results for Obesity Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2614347778","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614347778?lang=en_us&edition=fundamental","pubTime":"2026-02-25 09:48","pubTimestamp":1771984131,"startTime":"0","endTime":"0","summary":"United Laboratories International (HKG:3933) said its Phase 2 clinical trial of UBT251 Injection, a Class 1 innovative drug developed by its wholly owned unit, has been completed in Chinese patients w","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["UBCP","03933","BK1191","BK4211"],"gpt_icon":0},{"id":"1169113647","title":"The United Laboratories (3933) Completes Phase II Clinical Trial for UBT251 Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=1169113647","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169113647?lang=en_us&edition=fundamental","pubTime":"2026-02-24 17:04","pubTimestamp":1771923850,"startTime":"0","endTime":"0","summary":"The United Laboratories International Holdings Limited (3933) announced the completion of its Phase II clinical trial for UBT251 Injection in participants with overweight or obesity. According to the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f1cb9c263e4906c971f3030dfa725fa8","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03933"],"gpt_icon":0},{"id":"2613796115","title":"Triple Agonist Ubt251 Delivers up to 19.7% Mean Weight Loss After 24 Weeks in Phase 2 Trial in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2613796115","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613796115?lang=en_us&edition=fundamental","pubTime":"2026-02-24 17:00","pubTimestamp":1771923618,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f1cb9c263e4906c971f3030dfa725fa8","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nTUC86X7WC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["03933","BK1191"],"gpt_icon":0},{"id":"1110346029","title":"UNITED LAB's UBT251 Injection Concludes Phase II Trial in Chinese Overweight/Obesity Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=1110346029","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110346029?lang=en_us&edition=fundamental","pubTime":"2026-02-24 16:38","pubTimestamp":1771922318,"startTime":"0","endTime":"0","summary":"UNITED LAB (03933) announced that the Phase II clinical study for its independently developed Class 1 innovative drug, UBT251 injection, has been completed in Chinese patients with overweight or...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f37ea4482eb71651542a4cd5fb933659","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","03933"],"gpt_icon":0},{"id":"2613579557","title":"TUL unit United Biotechnology completes Phase II trial of UBT251 injection in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2613579557","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613579557?lang=en_us&edition=fundamental","pubTime":"2026-02-24 16:33","pubTimestamp":1771922001,"startTime":"0","endTime":"0","summary":"The United Laboratories International Holdings said its wholly owned subsidiary, The United Bio-Technology  Co., Ltd., has completed a Phase II clinical trial in China for its independently developed UBT251 injection in overweight and obese patients. The company said the trial met expectations and it plans to initiate a Phase III study in China in a timely manner, noting UBT251 is a long-acting triple-target receptor agonist of GLP-1/GIP/GCG and has clinical trial approvals in China and/or the United States for multiple indications.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TUL - The United Laboratories International Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Servi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nNDL9Cv5R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","03933"],"gpt_icon":0},{"id":"2610594519","title":"Assessing United Laboratories International Holdings (SEHK:3933) Valuation After UBT251 Clinical Trial Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2610594519","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610594519?lang=en_us&edition=fundamental","pubTime":"2026-02-11 22:29","pubTimestamp":1770820182,"startTime":"0","endTime":"0","summary":"United Laboratories International Holdings (SEHK:3933) has attracted fresh attention after China’s National Medical Products Administration approved clinical trials for UBT251 Injection, a self developed multi target peptide agonist for obstructive sleep apnea with obesity.\nSee our latest analysis for United Laboratories International Holdings.\nThat approval has arrived at a time when the stock’s short term momentum is picking up, with a 7 day share price return of 10.46% and a year to date...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3933/united-laboratories-international-holdings-shares/news/assessing-united-laboratories-international-holdings-sehk393","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3933/united-laboratories-international-holdings-shares/news/assessing-united-laboratories-international-holdings-sehk393","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4211","DCF","03933","BK1191","UBCP"],"gpt_icon":0},{"id":"2610632863","title":"The United Laboratories International Unit's Infection Drug Passes Chinese Regulator's Consistency Evaluation","url":"https://stock-news.laohu8.com/highlight/detail?id=2610632863","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610632863?lang=en_us&edition=fundamental","pubTime":"2026-02-09 19:36","pubTimestamp":1770636998,"startTime":"0","endTime":"0","summary":"The United Laboratories International (HKG:3933) said the Roxithromycin Capsules passed China's National Medical Products Administration's consistency evaluation of quality and efficacy for generic dr","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["UBCP","03933","BK4211","BK1191"],"gpt_icon":0},{"id":"2610639618","title":"BRIEF-United Laboratories International Says Roxithromycin Capsules Passed Consistency Evaluation Conducted By China's NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=2610639618","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610639618?lang=en_us&edition=fundamental","pubTime":"2026-02-09 18:32","pubTimestamp":1770633123,"startTime":"0","endTime":"0","summary":"BRIEF-United Laboratories International Says Roxithromycin Capsules Passed Consistency Evaluation Conducted By China's NMPAFeb 9 (Reuters) - United Laboratories International Holdings Ltd 3933.HK:ROXI","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nFWN3Z50ER:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","03933"],"gpt_icon":0},{"id":"1151052218","title":"The United Laboratories (3933) Announces Roxithromycin Capsules Passed Consistency Evaluation","url":"https://stock-news.laohu8.com/highlight/detail?id=1151052218","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151052218?lang=en_us&edition=fundamental","pubTime":"2026-02-09 18:21","pubTimestamp":1770632472,"startTime":"0","endTime":"0","summary":"The United Laboratories International Holdings Limited (3933) announced that Roxithromycin Capsules (150mg) developed by its wholly-owned subsidiary, Zhuhai United Laboratories Co., Ltd, Zhongshan...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03933"],"gpt_icon":0},{"id":"1132218222","title":"United Laboratories Passes Consistency Evaluation for Roxithromycin Capsules","url":"https://stock-news.laohu8.com/highlight/detail?id=1132218222","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132218222?lang=en_us&edition=fundamental","pubTime":"2026-02-09 18:12","pubTimestamp":1770631939,"startTime":"0","endTime":"0","summary":"United Laboratories (03933) announced that its wholly-owned subsidiary, Zhuhai United Laboratories Zhongshan Branch, has received approval from the National Medical Products Administration for the...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","03933"],"gpt_icon":0},{"id":"2610636938","title":"United Laboratories International -  Roxithromycin Capsules Passed Consistency Evaluation Conducted by China's Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2610636938","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610636938?lang=en_us&edition=fundamental","pubTime":"2026-02-09 18:08","pubTimestamp":1770631706,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nFWN3Z50ER:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","03933"],"gpt_icon":0},{"id":"2610369846","title":"TUL erhält Zulassung für Roxithromycin-Kapseln nach Bestehen der Konsistenzbewertung","url":"https://stock-news.laohu8.com/highlight/detail?id=2610369846","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610369846?lang=en_us&edition=fundamental","pubTime":"2026-02-09 18:07","pubTimestamp":1770631655,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TUL - The United Laboratories International Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on February 09, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nNDL5x6p1x:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03933","BK1191"],"gpt_icon":0},{"id":"2610813336","title":"The United Laboratories International Holdings Limited (HKG:3933) Looks Inexpensive But Perhaps Not Attractive Enough","url":"https://stock-news.laohu8.com/highlight/detail?id=2610813336","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610813336?lang=en_us&edition=fundamental","pubTime":"2026-02-09 12:40","pubTimestamp":1770612019,"startTime":"0","endTime":"0","summary":"With a price-to-earnings (or \"P/E\") ratio of 7.5x The United Laboratories International Holdings Limited ( HKG:3933...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3933/united-laboratories-international-holdings-shares/news/the-united-laboratories-international-holdings-limited-hkg39-5","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3933/united-laboratories-international-holdings-shares/news/the-united-laboratories-international-holdings-limited-hkg39-5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1191","03933"],"gpt_icon":0},{"id":"1175334452","title":"United Lab Shares Surge Over 7% Intraday as UBS Sees Market Undervaluing UBT251 Sales Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=1175334452","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175334452?lang=en_us&edition=fundamental","pubTime":"2026-02-06 10:12","pubTimestamp":1770343950,"startTime":"0","endTime":"0","summary":"UNITED LAB (03933) saw its shares rise more than 7% during the trading session. At the time of writing, the stock was up 5.62%, trading at HK$13.34, with a turnover of HK$165 million. Recently,...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03933","BK1191"],"gpt_icon":0},{"id":"1163065430","title":"The United Laboratories International Holdings Limited (03933) Announces Monthly Return for January 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1163065430","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163065430?lang=en_us&edition=fundamental","pubTime":"2026-02-05 12:45","pubTimestamp":1770266751,"startTime":"0","endTime":"0","summary":"The United Laboratories International Holdings Limited (03933) released its monthly return on movements in securities for January 2026. Authorized share capital remains at 3,800,000,000 ordinary...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03933"],"gpt_icon":0},{"id":"1129160772","title":"UNITED LAB Shares Rise Nearly 3% as Its Self-Developed Innovative Drug UBT251 Injection Receives Clinical Trial Implied Permission for OSA Indication","url":"https://stock-news.laohu8.com/highlight/detail?id=1129160772","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129160772?lang=en_us&edition=fundamental","pubTime":"2026-02-05 10:56","pubTimestamp":1770260215,"startTime":"0","endTime":"0","summary":"Shares of UNITED LAB (03933) climbed close to 3%. At the time of writing, the stock was up 2.7%, trading at HK$12.17, with a turnover of HK$54.12 million. The increase follows an announcement from...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","03933","06978","159992","BK4585","BK4588","BK1191","VXUS","BK1161","VT"],"gpt_icon":0},{"id":"2608987076","title":"BRIEF-United Laboratories International Gets Approval For Clinical Trial Of UBT251 Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2608987076","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608987076?lang=en_us&edition=fundamental","pubTime":"2026-02-03 23:07","pubTimestamp":1770131220,"startTime":"0","endTime":"0","summary":"BRIEF-United Laboratories International Gets Approval For Clinical Trial Of UBT251 InjectionFeb 3  - United Laboratories International Holdings Ltd 3933.HK:APPROVAL FOR CLINICAL TRIAL OF UBT251 INJECTION FOR OSA FROM NMPAFurther company coverage: 3933.HK ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nFWN3YZ07J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","03933"],"gpt_icon":0},{"id":"2608875924","title":"United Laboratories Gets China Nod for Unit's Sleep Apnea Drug Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2608875924","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608875924?lang=en_us&edition=fundamental","pubTime":"2026-02-03 20:24","pubTimestamp":1770121498,"startTime":"0","endTime":"0","summary":"The United Laboratories International  obtained approval for the clinical trial application of UBT251 injection from  China's National Medical Products Administration, according to a Tuesday Hong Kong bourse filing.The drug was developed by The United Bio-Technology , a unit of the firm, and is indicated to treat moderate to severe obstructive sleep apnea with obesity.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1191","BK4211","03933","UBCP"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tul.com.cn","stockEarnings":[{"period":"1week","weight":0.0032},{"period":"1month","weight":0.0387},{"period":"3month","weight":-0.011},{"period":"6month","weight":-0.1671},{"period":"1year","weight":0.0201},{"period":"ytd","weight":0.0897}],"compareEarnings":[{"period":"1week","weight":-0.0122},{"period":"1month","weight":-0.0275},{"period":"3month","weight":0.0202},{"period":"6month","weight":0.052},{"period":"1year","weight":0.109},{"period":"ytd","weight":0.0293}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"The United Laboratories International Holdings Limited is an investment holding company principally engaged in the sales of intermediate products, bulk medicine and finished products. The Company operates its business through three segments. The Intermediate Products segment is engaged in the sale of intermediate products. The Bulk Medicine segment is engaged in the sale of bulk medicine. The Finished Products segment is engaged in the sale of antibiotics finished products, non-antibiotics finished products and capsule casings. Through its subsidiaries, the Company is also engaged in the production and sale of organic fertilizer.","yearOnYearQuotes":[{"month":1,"riseRate":0.368421,"avgChangeRate":-0.033088},{"month":2,"riseRate":0.736842,"avgChangeRate":0.074366},{"month":3,"riseRate":0.666667,"avgChangeRate":0.040428},{"month":4,"riseRate":0.611111,"avgChangeRate":0.081119},{"month":5,"riseRate":0.666667,"avgChangeRate":0.040685},{"month":6,"riseRate":0.277778,"avgChangeRate":-0.012388},{"month":7,"riseRate":0.526316,"avgChangeRate":0.011895},{"month":8,"riseRate":0.473684,"avgChangeRate":0.025474},{"month":9,"riseRate":0.421053,"avgChangeRate":-0.006971},{"month":10,"riseRate":0.631579,"avgChangeRate":-0.000903},{"month":11,"riseRate":0.473684,"avgChangeRate":-0.023163},{"month":12,"riseRate":0.421053,"avgChangeRate":0.011153}],"exchange":"SEHK","name":"UNITED LAB","nameEN":"UNITED LAB"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"UNITED LAB(03933),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest UNITED LAB(03933) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"UNITED LAB,03933,UNITED LAB股票,UNITED LAB股票老虎,UNITED LAB股票老虎国际,UNITED LAB行情,UNITED LAB股票行情,UNITED LAB股价,UNITED LAB股市,UNITED LAB股票价格,UNITED LAB股票交易,UNITED LAB股票购买,UNITED LAB股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"UNITED LAB(03933),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest UNITED LAB(03933) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}